Our future studies will focus on analyses of additional RCC cell lines to determine whether the low frequency of FABP7 expression is a consequence of selecting tumor cells for in vitro growth, and if so, will provide new insights into regulation of FABP7 expression. The gene discussed is FABP7; the disease is renal cell carcinoma.